Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1747* | 2021 |
International incidence of childhood cancer, 2001–10: a population-based registry study E Steliarova-Foucher, M Colombet, LAG Ries, F Moreno, A Dolya, F Bray, ... The lancet oncology 18 (6), 719-731, 2017 | 1694 | 2017 |
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials RC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, ... The Lancet Oncology 21 (2), 271-282, 2020 | 1365 | 2020 |
Integrase inhibitors to treat HIV/AIDS Y Pommier, AA Johnson, C Marchand Nature reviews Drug discovery 4 (3), 236-248, 2005 | 989 | 2005 |
Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications P Yilmaz, R Kottmann, D Field, R Knight, JR Cole, L Amaral-Zettler, ... Nature biotechnology 29 (5), 415-420, 2011 | 712 | 2011 |
Natural gas hydrates: Energy resource potential and associated geologic hazards, AAPG Memoir 89 TS Collett, A Johnson, CC Knapp, R Boswell AAPG, 2010 | 518 | 2010 |
Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase AA Johnson, AS Ray, J Hanes, Z Suo, JM Colacino, KS Anderson, ... Journal of Biological Chemistry 276 (44), 40847-40857, 2001 | 471 | 2001 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 440* | 2021 |
A broadly implementable research course in phage discovery and genomics for first-year undergraduate students TC Jordan, SH Burnett, S Carson, SM Caruso, K Clase, RJ DeJong, ... MBio 5 (1), 10.1128/mbio. 01051-13, 2014 | 438 | 2014 |
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials A Drilon, S Siena, R Dziadziuszko, F Barlesi, MG Krebs, AT Shaw, ... The Lancet Oncology 21 (2), 261-270, 2020 | 411 | 2020 |
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
Financial account up-front incentives management system and method A Johnson, R Riddett US Patent App. 10/891,410, 2005 | 261 | 2005 |
Scanning tunnelling microscopy of charge-density waves in transition metal chalcogenides RV Coleman, B Giambattista, PK Hansma, A Johnson, WW McNairy, ... Advances in Physics 37 (6), 559-644, 1988 | 238 | 1988 |
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 233 | 2022 |
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 218 | 2022 |
Prophage-mediated defence against viral attack and viral counter-defence RM Dedrick, D Jacobs-Sera, CAG Bustamante, RA Garlena, TN Mavrich, ... Nature microbiology 2 (3), 1-13, 2017 | 217 | 2017 |
Exonuclease proofreading by human mitochondrial DNA polymerase AA Johnson, KA Johnson Journal of Biological Chemistry 276 (41), 38097-38107, 2001 | 196 | 2001 |
The influence of phosphate and crop species on Endogone spores and vesicular-arbuscular mycorrhiza under field conditions DS Hayman, AM Johnson, I Ruddlesdin Plant and soil 43, 489-495, 1975 | 185 | 1975 |
Expression, purification, and initial kinetic characterization of the large subunit of the human mitochondrial DNA polymerase SW Graves, AA Johnson, KA Johnson Biochemistry 37 (17), 6050-6058, 1998 | 184 | 1998 |
Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs JY Feng, AA Johnson, KA Johnson, KS Anderson Journal of Biological Chemistry 276 (26), 23832-23837, 2001 | 183 | 2001 |